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Objectives . This study examined the influence of left atrial
spontaneous echo contrast on the subsequent stroke or embolic
event rate and on survival in patients with nonvalvular atrial
fibrillation .
Background. Left atrial spontaneous echo contrast is associ-
ated with atrial fibrillation and a history of previous stroke or
other embolic events. However, the prognostic implications of
spontaneous contrast in patients with nonvalvular atria) fibrilla-
tion are unknown
Method. The study group comprised 272 consecutive patients
with nonvalvular atria) fibrillation undergoing transesophageal
echocardiography . Clinical and echocardiographic data were col-
lected at baseline, and patients were prospectively followed up,
and all strokes, other embolic events and deaths were docu-
mented. The relation between spontaneous contrast at baseline
and subsequent stroke, other embolic events and survival was
analyzed .
Results. Left atria[ spontaneous echo contrast was detected at
baseline in 161 patients (59%). The mean follow-up was 17.5
months. The stroke or other embolic event rate was 12%/year (15
strokes, 3 transient ischemic attacks, 2 peripheral embolisms) in
Left atrial spontaneous echo contrast refers to swirling smoke-
like echoes that are detected by transesophageal echocardiog-
raphy in conditions favoring stasis of blood in the left atrium .
We previously showed (1) that left atrial spontaneous echo
contrast is significantly associated with the presence of atrial
fibrillation, mitral stenosis, left atrial enlargement and left
atrial thrombus. Left atrial spontaneous echo contrast has also
been shown to be associated with a history of thromboembo-
lism, both in patients with mitral stenosis or prosthetic mitral
valves (1,2) and in those with nonvalvular atrial fibrillation (1) .
However, the prognostic implications of left atrial spontaneous
echo contrast in patients with nonvalvular atrial fibrillation are
unknown. The aim of the present study was to determine
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patients with, compared with 3°!o/year (5 strokes) in patients
without, baseline spontaneous contrast (p = 0.002) . In 149
patients without previous thromboembolism, the event rate was
9.51%e/Year in patients with and 2 .2%/year in patients without
spontaneous contrast (p = 0.003). There were 25 deaths in
patients with and 11 deaths in patients without spontaneous
contrast . Patients with spontaneous contrast had significantly
reduced survival (p = 0.025) . On multivariate analysis, sponta-
neous contrast was the only positive predictor (odds ratio 3 .5, p =
0.03) and warfarin therapy on follow-up the only negative predic-
tor (odds ratio 0.23, p = 0 .02) of subsequent stroke or other
embolic events .
Conclusions. Transesophageal echocardiography can risk-
stratify patients with nonvalvular atrial fibrillation by identifying
left atria] spontaneous echo contrast. These patients have both a
significantly higher risk of developing stroke or other embolic
events and a reduced survival, and they may represent a subgroup
in whom the risk/benefit ratio of anticoagulation may be most
favorable .
(J Ant Coll Cardiol 1994 ;24:755-62)
prospectively the influence of left atrial spontaneous echo
contrast on both the subsequent development of stroke or
other embolic events and survival in a large series of patients
with nonvalvular atrial fibrillation .
Methods
Study patients . The study patients comprised 272 consec-
utive patients with nonvalvular atrial fibrillation undergoing
transesophageal echocardiography at our institution between
January 1989 and January 1993 . Criteria for inclusion were
atrial fibrillation with a duration >7 days, with no evidence of
rheumatic mitral stenosis, moderate or severe mitral regurgi-
tation and no history of mitral valve surgery . All clinical charac-
teristics, including patient gender and age, details of previous
stroke or embolic events and study indication, were recorded at
baseline. There were 185 men and 87 women with a mean
(-"SD)
age of 68 ± 11 years (range 24 to 87)
. The indications for
transesophageal echocardiographic studies were exclusion of left
atrial thrombus in patients without previous thromboembolism
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(n = 129,47% suspected cardiac source of embolism (n = 106,
39%), suspected infective endocarditis (n = 11, 4%), assessment
of mitral regurgitation (n = 5, 2%), aortic valve disease (n = 6,
2%) and miscellaneous findings (n = 15, 6%) .
Echocardiographie studies. All patients underwent both
transthoracic and transesophageal echocardiographic studies,
with all echocardiographic data recorded prospectively at
baseline. Transthoracic studies were performed using 2
.5- and
3.5-MHz phased array transducers with a Hewlett-Packard
Sonos 1000 .". em using all standard echocardiographic win-
dows. Global left ventricular systolic function was assessed
semiquantitatively from the parasternal and apical views and
graded ac normal or mild, moderate or severe impairment .
Left atria( dimension and left ventricular wall thickness were
measured according to standard M-mode criteria (3). Only
moderate or severe left ventricular hypertrophy (wall thickness
>l3 mm) was considered significant. Mitral annular calcifica-
tion was diagnosed on M-mode and two-dimensional echocar-
diography by the presence of an echo-dense band posterior to
the posterior mitral leaflet at the atrioventricular junction with
motion parallel to that of the free left ventricular wall (4) .
Mitral regurgitation was assessed semiquantitatively by color
and continuous wave Doppler and was graded as trivial or
mild, moderate or severe (5) .
Transesophageal echocardiography was performed using
5-MHz phased array transducer(s) according to standard pro-
tocols (6) . Written informed consent was obtained in all
patients. Biplane examination was performed in 145 patients,
monoplane in 115 and multiplane in 12 . No complications were
recorded . Only the first study was analyzed if patients had
subsequent studies.
Left atria( spontaneous echo contrast and left atrial throm-
bus, if present, were specifically examined . Left atrial sponta-
neous echo contrast was diagnosed by the presence of charac-
teristic dynamic smokelike swirling echoes in the left atrium or
the atrial appendage, distinct from background white noise
caused by excessive gain (7). The presence or absence of left
atrial spontaneous echo contrast was determined by two
independent experienced observers, and any discrepancy was
resolved by consensus . Left atrial thrombus was diagnosed by
the presence of an echo-dense mass in the left atrium or the
left atrial appendage distinct from the endocardium and the
pectinate muscles of the left atrial appendage (8). The pres-
ence of atheroma in the thoracic aorta was examined and
classified as simple or complex according to previously defined
criteria (9) .
Follow-up. Patients were prospectively followed up to de-
termine the incidence of subsequent stroke or other embolic
events. Follow-up information was obtained by telephone
interviews, careful review of hospital records and direct contact
with the patients' primary physicians. Patients' medication
history, including warfarin and aspirin therapy at the time of
follow-up, was recorded . The primary end point was stroke or
other embolic events. Stroke was defined as a definite focal
neurologic deficit of acute onset consistent with a vascular
event lasting >24 h
. A transient ischemic attack was defined as
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Table 1 . Baseline Clinical and Echocardiographic Findings Related
to Left Atrial Spontaneous Echo Contrast
Data presented arc mean value I SD or number ('' .) of patients . LV = left
ventricular : SEC _, spontaneous echo contrast .
focal neurologic deficit of sudden onset that resolved com-
pletely in <24 It . Transient ischemic attack was considered an
embolic event . The criteria for embolism to viscera or to an
extremity were pain and other symptoms and signs consistent
with abrupt vascular occlusion . The results of investigations
performed after the suspected thromboembolic event were
also recorded . The secondary end point was all-cause mortal-
ity. Sudden death was not considered an embolic event . All end
point events were assessed by a worker unaware of the results
of the echocardiographic studies.
Statistical analysis. Results are reported as mean value
1 SD, unless otherwise stated . Unpaired Student t test was used
to compare continuous variables, and chi-square test to com-
pare categoric variables . Multivariate logistic regression anal-
ysis (maximal likelihood ratio method) was used to identify
independent predictors of subsequent thromboembolic events.
Actuarial survival and freedom from stroke or other embolic
events were plotted by the Kaplan-Meier method, and sub-
groups were compared by the log-rank test . Odds ratios were
shown with 95% confidence intervals, and statistical signifi-
cance was defined as a two-tailed p value <0.05 . The statistical
package SPIDA (version 6) was used for statistical analysis .
Results
Baseline clinical and echocardiographic findings. Left
atrial spontaneous echo contrast was detected by transesoph-
ageal echocardiography in 161 (59%) of the 272 patients .
Forty-two patients (15%) had moderate or severe left ventric-
ular systolic dysfunction, and 29 (11%) had significant left
ventricular hypertrophy . Mitral annular calcification was de-
tected in 84 patients (31%) . Ninety-six patients (35%) had
simple thoracic aortic atheroma, and 28 (10%) had complex
atheroma. Eighty-eight patients (32%) had a history of stroke
or transient ischemic attack, and 24 (9%) had a history of an
embolic event affecting either an extremity or a visceral organ .
The clinical and echocardiographic findings of patients with
(group A) and without (group B) baseline left atrial sponta-
neous echo contrast are compared in Table 1 . Patients in group
SEC
Present
(n = 161)
SEC
Absent
(n = III)
p
Value
Previous thromboembolism 86 (5Y7)
26 (23ri) < 0.001
Left atrial thrombus
19 (I2') u < 0.001
Age (yr) 70 *_ 9 65 12
<
0011
Left atrial dimension (mm)
511 t 7 45 x 7 < (LIMIT
Complex aortic atheruma
23 (14<<) 5 (4 .5''.) (1.(1119
Mitral annular calcification 57 (35',)
2 7 (24'7)
(10)
Male patients 103(041
.
) 5$ (52 ( i)
11.055
Moderate or severe LV dysfunction
28 (17'7 ) 14 (13<(' ) IL-'S4
Significant LV hypertrophy 15 (11' ;) I I (1W ) 0
.739
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Figure 1. Cumulative freedom
from stroke or other embolic
events in patients with tSEC
present) and without (SEC ab-
sent) baseline left atrial spontane-
ous echo contrast (SEC) .
I
A were significantly older (p < 0 .001), had a higher incidence
of previous thromboembolic events (p < 0 .001), larger left
atrial dimension (p < 0.001) and higher prevalence of complex
thoracic aortic atheroma (p = 0 .009) . The prevalence of mitral
annular calcification, moderate or severe left ventricular sys-
tolic dysfunction or significant left ventricular hypertrophy
were not different between the two groups .
Nineteen patients (7%) were found to have a left atrial
thrombus, and three had a left ventricular apical thrombus .
The left atrial thrombus was situated in the atrial appendage in
16 patients and at the orifice of the appendage in 3 . All 19
patients with left atrial thrombus had left atrial spontaneous
echo contrast. These 22 patients were excluded from all
subsequent analysis .
Follow-up . Follow-up was complete in 233 patients (93%),
with a mean duration of follow-up of 17 .5 ± 10 months
(maximal follow-up 47 months) . Seventeen patients (7%) were
lost to follow-up . Forty-five patients (34%) in group A and 11
(11 %o) in group B were receiving anticoagulation therapy with
warfarin on follow-up (p < 0.001), whereas 42 patients (32%)
in group A and 47 (47%) in group B were receiving aspirin
therapy (p = 0.02).
Twenty-five patients had a stroke or other embolic event
during follow-up (overall event rate 7%/year). The total event
rate was 12%/year in group A and 3%/year in group B, and the
event rate for stroke or transient ischemic attack only was
10.5%/year in group A and 3%/year in group B . Patients in
group A had a significantly decreased freedom from stroke or
other embolic event compared with those in group B (p =
0.002) (Fig. 1) .
In group A, 15 patients had a stroke, two fatal . Fourteen
patients had a cerebral computed tomographic scan performed
after the event ; these showed nonhemorrhagic cerebral infarc-
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tion in 13 patients and no significant abnormality in I . The one
patient who did not have a computed tomographic scan died
within 24 h of the onset of neurologic deficit, and autopsy was
not performed . Three patients had transient ischemic attacks.
A computed tomographic scan was performed in one of these
three patients and showed no significant abnormalities . One
patient had an acute embolism to the right brachial artery, and
another had an acute embolism to the left femoral artery .
These two patients underwent surgical embolectomy, which
confirmed the diagnosis. In the 45 patients in group A receiv-
ing warfarin therapy, the incidence of stroke or other embolic
events was 7%/year compared with 14 .5%/year in the 88
patients not receiving warfarin therapy (p = 0 .15) . Thirty of
these 45 patients (67%) receiving warfarin therapy had a
previous embolism, whereas only 34 patients (39%) of the 88
patients not receiving warfarin had such a history (p = 0.002) .
In group B, five patients had a stroke on follow-up, two
fatal. Three patients had a computed tomographic scan per-
formed; these showed nonhemorrhagic cerebral infarction in
one patient and no significant abnormalities in two . One of the
latter two patients had a brainstem event that was confirmed by
magnetic resonance imaging. The two patients who died did
not have a computed tomographic scan performed . No patient
in group B had a peripheral embolism or transient ischemic
attack on follow-up.
There were a total of 36 deaths on follow-up (overall
all-cause mortality 10 .5%/year). According to life-table analy-
sis, patients in group A had a significantly reduced survival
compared with those in group B (p = 0.025) (Fig. 2) . In group
A, there were 25 deaths . Nine patients died of cardiovascular
causes, two died of fatal stroke, six died of complications
secondary to a stroke or peripheral embolism, four died of
cancer and four of other noncardiovascular causes . In group B,
1 .0
I
SEC absent
I
1 SEC present
L - -I
p=0 .002
1
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30 40
t-0118W tip tine (months)
NO. AT
RISK
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20 2
SEC PItES1iNT 1 33 93 39 11 2
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.025
mo t,
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there were I I deaths . Four patients died of cardiovascular
causes, two died of fatal stroke, three died of cancer and two of
other causes .
Patients without a history of stroke or embolic events . One
hundred forty-nine patients did not have history of previous
stroke or other embolic events . Left atrial spontaneous echo
contrast was detected in 69 of these patients (46%) . In these
149 patients, the event rate for stroke or other embolic events
was 9 .5%/year in patients with baseline left atrial spontaneous
Figure 3. Cumulative freedom
from stroke or other embolic
events in the 149 patients without
a history of thrombo embolism
SEC = left atrial spontaneous
echo contrast .
1 .0
.9
.8-
.7-
.6-
.S .
A-
I
p=0 .003
I
I
SEC present
i
SEC absent
Figure 2 . Survival curves of pa-
tients with (SEC present) and with-
out (SEC absent) baseline left
atria) spontaneous echo contrast
(SEC) .
echo contrast and2.2%/year in patients without. In the pa-
tients with spontaneous echo contrast, seven had a stroke, and
one patient had an acute embolism to the left femoral artery .
In the patients without spontaneous echo contrast, three had a
stroke. In these patients with no history of previous thrombo-
embolism, patients with left atrial spontaneous echo contrast
had significantly decreased freedom from stroke or other
embolic events (p = 0.003) (Fig. 3). There were 18 deaths on
follow-up, 12 in the group with spontaneous echo contrast and
LEUNG ET AL .
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Figure 4. Survival curves of 149
patients without a history of throm-
boembolism . SEC = left atrial
spontaneous echo contrast .
7 .
1 .0
6 in the group without. On life-table analysis, patients with left
atrial spontaneous echo contrast had significantly reduced
survival (p = 0 .02) (Fig. 4) .
Predictors of subsequent stroke or other embolic events .
Table 2 shows the results of multivariate logistic regression
analysis performed to identify independent predictors of sub-
sequent stroke or other embolic events in this cohort of 233
patients on the basis of clinical characteristics, baseline echo-
cardiographic variables and warfarin or aspirin therapy on
follow-up. The presence of left atrial spontaneous echo con-
trast at baseline was the only independent positive predictor,
and anticoagulation therapy with warfarin on follow-up the
only independent negative predictor, of subsequent stroke or
other embolic events. Gender, age, previous thromboembo-
lism, moderate or severe left ventricular systolic dysfunction,
Table 2. Multivariate Analysis of Clinical and Echocardiographic
Factors Related to Subsequent Thromboembolism in 233 Patients
With Nonvalvular Atrial Fibrillation
CI = confidence interval; LV = left ventricular .
I
SEC present
i
i
i
p=0 .02
10
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SEC absent
20 30
40
significant left ventricular hypertrophy, left atria) dimension,
left atrial spontaneous echo contrast, mitral annular calcifica-
tion, complex thoracic aortic atheroma and warfarin or aspirin
therapy on follow-up were used as covariates .
Complex thoracic aortic atheroma was not a significant
predictor on either univariate (p = 0 .5) or multivariate anal-
ysis. The results of the multivariate analysis were not altered
after patients with complex atheroma were excluded from the
analysis, with spontaneous echo contrast being an independent
positive predictor (p = 0.04, odds ratio 3.3, 95% confidence
interval (01 1 .1 to 10.2) and warfarin therapy on follow up a
negative predictor (p = 0.02, odds ratio 0 .2, 95% CI 0.05 to
0.75) .
Discussion
This large prospective study is the first to examine the
prognostic implications of left atrial spontaneous echo contrast
in patients with nonvalvular atrial fibrillation . We showed that
patients with left atrial spontaneous echo contrast have on
follow-up both a higher risk of developing stroke or other
embolic events and a reduced actuarial survival . Moreover, the
presence of left atrial spontaneous echo contrast was the only
independent positive predictor of subsequent thromboembolic
events, including stroke, transient ischemic attack and periph-
eral embolism .
Prevalence of left atrial spontaneous echo contrast . Left
atrial spontaneous contrast was detected in 59% of the pa-
tients
. The reported prevalence of left atrial spontaneous echo
contrast ranges from 16% to 19% (1,10) in all patients undergo-
ing transesophageal echocardiography and is higher in patients
with mitral stenosis or a mitral prosthesis (25% to 74%) (1,2,10) .
Left atrial spontaneous echo contrast has been shown to be
Follow up time (months)
No . AT RISK
SEC ABSENT 00
66
44 15 1
SEC PRISM69 47
16
2 0
p
Value Odds Ratio 95% Cl
Spontaneous echo contrast 0 .03 3 .5 1 .1-10 .5
Warfarin therapy on follow-up 0 .02 0.23 0.07-0.8
Previous thromboembolism 0 .11 2 0.8-5 .6
Moderate or severe LV dysfunction 0 .17 2.3 0 .7-7.3
Aspirin therapy 0 .19 0.5 0.2-1 .4
Significant LV hypertrophy 0 .37 0.4 0.05-3.1
Female gender 0 .38 1 .6 0.6-4.2
Mitral annular calcification 0 .58 1 .3 0.5-3.4
Left atrial dimension 0 .63 1 0.9-1
Age 0 .89 1 0.9-1
Complex aortic atheroma 0 .98 1 0 .2-4.3
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strongly associated with the presence of atrial fibrillation
(1), but
previous reports of its prevalence in nonvalvular atrial fibrillation
are sparse. Our group reported a prevalence of 47% in a smaller
series of patients (1), and Tsai et al
. (11) reported a prevalence of
24% in a series of 103 patients .
Thromboembolic risk in nonvalvular atrial fibrillation .
There is a definite increase in the risk of stroke or other
embolic events in patients with nonvalvular atrial fibrillation
(12,13)
. The reported incidence of stroke or other embolic
events in these patients ranges from 3%/year to 7.4%/year
(14-18)
. In the placebo arm of the Stroke Prevention in Atrial
Fibrillation study (15),
the event rate for stroke, transient
ischemic attack or systemic embolism was 9%/year . The present
study confirmed the significantly increased risk of thromboembo-
lism in these patients, with an event rate of 5 .8%/year for stroke,
6.7%/year for stroke or transient ischemic attack, and 7%/year for
all thrombocmbolic events .
The risk of subsequent stroke and other embolic events is
clearly not uniform among patients with nonvalvular atrial
fibrillation (13) . There has been considerable interest in iden-
tifying clinical risk factors for thromboembolism in these
patients. Female gender (19), older age group (20), hyperten-
sion (15,20,21), recent congestive heart failure (22) and a
history of thromboembolism (20,22) have been reported to be
useful clinical predictors in some studies . Analysis of the result
of the Copenhagen Atrial Fibrillation, Aspirin, Antikoagula-
tion (AFASAK) study (23) for risk factors showed that only a
history of previous myocardial infarction was a useful predictor
of thromboembolism .
The search for echocardiographic predictors of thrombo-
embolism has also yielded conflicting results . Although left
atrial enlargement is the most frequently reported predictor
(19,21,24-26), left ventricular dysfunction (24), left ventricular
hypertrophy (25) and mitral annular calcification (15,18) have
been shown to be significant in some studies . However, these
echocardiographic variables have not been predictive in other
series (23,27). Many of these studies were limited by being
retrospective in design (11,20,21,26,27), and factors associated
with a history of thromboembolism may not necessarily be risk
factors for subsequent events .
With the exception of the detection of left atrial thrombus,
transcsophageal echocardiography has not been previously
used to risk-stratify patients with nonvalvular atrial fibrillation .
Presence of left atrial thrombus, now reliably detectable by
transesophageal echocardiography (28), may define a sub-
group of patients at higher risk of thromboembolic events who
require anticoagulation. However, a left atrial thrombus was
detected in only 19 (7%) of our 272 patients and in 9 (6%) of
150 patients in the Castello et al . (10) study and therefore may
have limited applicability,
We previously showed (1) that left atrial spontaneous echo
contrast and left atrial thrombus are strongly linked and are
associated with a history of thromboembolic events . Therefore,
we postulated that the presence of spontaneous echo contrast
may also be predictive of subsequent thromboembolic events .
The present study showed that left atrial spontaneous echo
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contrast is the only significant independent predictor of the
increased risk of subsequent stroke or other embolic events .
Because the total patient group included a number of patients
with a history of previous thromboembolism with a higher
prevalence of spontaneous echo contrast who might be ex-
pected to have a higher risk of recurrent stroke or other
embolic events, we also analyzed the patient subgroup who did
not have a history of previous thromboembolism . Life-table
analysis demonstrated that these latter patients with spontane-
ous echo contrast also have both significantly decreased free-
dom from stroke or other embolic events and reduced survival
compared with those without spontaneous echo contrast .
Left atrial enlargement and older age group, although more
prevalent inpatients with left atrial spontaneous echo contrast,
were not significant predictors in the present study . Complex
thoracic aortic atheroma has been suggested as a useful
predictor of embolic events in recent studies (9,29), but it was
not predictive of embolism in the present study, even on
univariate analysis. However, the number of patients with this
abnormality was small in this series .
Left atrial spontaneous echo contrast and thromboembo-
lism. The strong predictive value of left atrial spontaneous
echo contrast raises the question of the possible mechanism
linking spontaneous echo contrast with thromboembolism. In
an earlier study, our group showed that left atrial spontaneous
echo contrast was independently related to hematocrit and
fibrinogen concentration (30) and may represent a hyper-
coagulable state resulting from the interaction between hema-
tologic factors favoring erythrocyte aggregation and hemo-
dynamic factors favoring stasis. Platelet aggregation has also
been implicated in the formation of spontaneous echo contrast
(31,32). We therefore postulate that spontaneous echo con-
trast may he a precursor of thrombus formation, especially in
foci of low blood flow such as the appendage . These thrombi
may then subsequently embolize to major organs .
The present study also showed that left atrial spontaneous
echo contrast is associated with more advanced atherosclerotic
disease in the thoracic aorta, which suggests that these patients
may also have more extensive atherosclerotic disease else-
where in the aorta and in the cerebral vessels. Systemic emboli-
zation, such as was responsible for stroke in these patients with
atrial fibrillation, may arise from abnormal segments in these
vessels and not necessarily from the heart .
Left atrial spontaneous echo contrast and mortality . The
all-cause mortality rate of patients in atrial fibrillation is about
twice that of patients in sinus rhythm (13,33,34) . This study is
the first to show that the mortality risk of patients with
nonvalvular atrial fibrillation can be further stratified accord-
ing to the presence or absence of left atrial spontaneous echo
contrast . The reduced survival of patients with spontaneous
echo contrast is most probably related to the excess thrombo-
embolic risk and associated vascular disease . Furthermore,
patients with spontaneous echo contrast were older, had a
higher prevalence of complex aortic atheroma and had a more
frequent history of previous thromboembolism consistent with
more extensive atherosclerotic vascular disease .
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Role of aarticoagerlant therapy
. Recent placebo-controlled
studies have shown that anticoagulation with warfarin de-
creases the thromboembolic risk in patients with nonvalvular
atrial fibrillation, but the role of aspirin remains uncertain
(14-18). In the present study, warfarin therapy was a signifi-
cant negative predictor of subsequent stroke or other embolic
events on multivariate analysis
. In patients with baseline
spontaneous echo contrast, the incidence of stroke or other
embolic events in those receiving warfarin therapy was 7%/
year in contrast to 14.5%/year in those not receiving warfarin
therapy. Although it did not reach statistical significance on
univariate analysis, this trend toward risk reduction with
warfarin therapy occurred despite a higher incidence of previ-
ous embolism in the former group of patients. Moreover,
patients receiving warfarin therapy were a highly selected
subgroup in whom the risk of developing an event was
considered high
. However, these findings must be interpreted
with caution because the study was only observational and did
not control for anticoagulation therapy . Nevertheless, these
results are consistent with the findings of randomized multi-
center trials (14-18) .
Study limitations. This was an observational study in a
cohort of patients where the presence or absence of spontane-
ous echo contrast and anticoagulation therapy were not con-
trolled, and there were differences in the baseline characteris-
tics of the two patient subgroups
. Nevertheless, spontaneous
echo contrast was present in -50% of the patients at the
baseline study, and multivariate analysis was used to allow for
these differences in the clinical characteristics of the two
patient subgroups . The adverse prognostic implications of the
presence of spontaneous echo contrast were highly significant
and were independent of history of previous thromboem-
holism .
No information was available about the natural history of
spontaneous echo contrast because serial transesophageal
studies were not routinely performed on follow-up or at the
time of a thromboembolic event . More information is required
to characterize more precisely any changes in spontaneous
echo contrast with time or with subsequent thromboembolic
events .
Clinical implications
. Patients with nonvalvular atrial fi-
brillation have about a fivefold increase in stroke rate com-
pared with patients in sinus rhythm (13) . Anticoagulation
therapy with warfarin in patients with nonvalvular atrial fibril-
lation has been shown to reduce this thromboembolic event
rate (14-18). However, warfarin therapy for patients with
nonvalvular atrial fibrillation is not uniformly prescribed be-
cause of concern about bleeding risk in this predominantly
elderly patient population
. This is illustrated by the finding that
only 24% of patients in the present study were receiving
warfarin therapy on follow-up . In the Stroke Prevention in
Atrial Fibrillation Study (15),
53% of the study patients were
considered ineligible for anticoagulation
. In the Stroke Pre-
vention in Nonrheumatic Atrial Fibrillation trial (32),
40% of
the patients screened were considered to have contraindica-
tions to anticoagulation
. Despite careful screening, warfarin
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therapy is associated with a significant increase in the risk of
bleeding (14-18) in patients with nonvalvular atrial fibrillation
.
In large, carefully controlled randomized trials, the reported
incidence of intracranial hemorrhage and major bleeding on
warfarin therapy was up to 2
.5%/year (16) .
The risk/benefit
ratio of systemic anticoagulation can be optimized by treating
patients at higher risk of developing subsequent thromboem-
bolism
. We have shown that transesophageal echocardiogra-
phy can be used to risk-stratify patients with nonvalvular atria]
fibrillation by identifying patients with left atrial Fpontaneous
echo contrast who have both a significantly higher risk of
developing stroke, transient ischemic attack or other embolic
events and reduced survival
. These patients may represent a
subgroup in whom the risk/benefit ratio of long-term antico-
agulation with warfarin therapy appears most favorable
. These
findings need to be tested in prospective, randomized, multi-
center trials .
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